Skip to main content
TipRanks
Go Ultimate75% OFF

Genscript Biotech (GNNSF) Q2 2025 Earnings Report

23 Followers

GNNSF Q2 2025 EPS Results

Actual EPS
-$0.02
Consensus EPS
$0.08
Beat/Miss
Missed by -$0.10
One Year Ago EPS
-$0.08

GNNSF Q2 2025 Revenue Results

Actual Revenue
$515.34M
Expected Revenue
$560.39M
Beat/Miss
Missed by -$45.05M
YoY Revenue Growth
-7.90%

Earnings Announcement Details

Quarter
Q2 2025
Date
08/17/2025
Time
Before Open
Conference Call
Sunday, August 17, 2025
GNNSF Upcoming Earnings

Genscript Biotech's next earnings date is estimated for March 24, 2027, based on past reporting schedules.

Q2 2025 Earnings Call Audio

GNNSF Q2 2025 Earnings Call
0:00 / 0:00

Q2 2025 Earnings Slide Deck

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

GNNSF Earnings History

GNNSF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 24, 20272026 (Q4)0.01--0.23――
Aug 17, 20262026 (Q2)0.00-0.06-0.02-168.18% (-0.04)
Mar 15, 20262025 (Q4)-0.03-0.231.48-115.54% (-1.71)
Aug 17, 20252025 (Q2)0.08-0.02-0.0873.49% (+0.06)
Mar 12, 20252024 (Q4)―1.48-0.062449.21% (+1.54)
Aug 09, 20242024 (Q2)-0.01-0.08-0.04-88.64% (-0.04)
Mar 10, 20242023 (Q4)-0.05-0.06-0.04-40.00% (-0.02)
Aug 20, 20232023 (Q2)―-0.04-0.0630.16% (+0.02)
May 08, 20232023 (Q1)―--0.12―
Mar 30, 20232022 (Q4)-0.06-0.04-0.9695.31% (+0.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed